Airway Management Devices Market to Grow at 6.21% CAGR Through 2030, Driven by FDA Approvals, AI and Next-Gen Devices | DelveInsight

Airway Management Devices Market to Grow at 6.21% CAGR Through 2030, Driven by FDA Approvals, AI and Next-Gen Devices | DelveInsight
Airway Management Devices Market Insights, Competitive Landscape and Market Forecast–2030
DelveInsight forecasts the airway management devices market to grow from USD 1.6B in 2023 to USD 2.3B by 2030 at a 6.21% CAGR, driven by rising respiratory diseases, surgeries, and innovation. Key players include Smiths Medical, Narang Medical, Intersurgical, Teleflex, Stryker, Medtronic, Dilon Technologies, Ambu A/S, and Medline Industries. Advances like AI-assisted systems, video laryngoscopes, and FDA approvals fuel market expansion.

DelveInsight’s “Airway Management Devices Market Insights, Competitive Landscape and Market Forecast–2030” report delivers a comprehensive analysis of the Airway Management Devices market globally.

Key Takeaways

  • Market size projection: As per DelveInsight’s analysis, the total market size of airway management devices is expected to surge significantly by 2030, reaching USD 2.3 billion from USD 1.6 billion in 2023, representing a steady CAGR of 6.21% during the forecast period from 2024 to 2030.

  • The report provides comprehensive analysis of the global airway management devices market segmented by Type (Infraglottic Devices including Endotracheal Tubes, Tracheostomy Tubes, and Others; Supraglottic Devices including Oropharyngeal Devices, Nasopharyngeal Devices, Laryngeal Airway Devices, and Others; Resuscitators, Laryngoscopes, and Others), Application (Emergency Medicine, Anesthesia, and Others), and End-User (Hospitals, Ambulatory Surgical Care Centers, and Others).

  • Key companies: Leading airway management devices companies include Smiths Medical PLC, Narang Medical Limited, Intersurgical Ltd., Teleflex Incorporated, Stryker Corporation, Medtronic PLC, Dilon Technologies Inc., Ambu A/S, Medline Industries, LP, and others, driving innovation in the sector.

  • Pipeline assets: Some of the key product developments in the airway management devices pipeline include advanced video laryngoscopes, AI-assisted airway management solutions, and next-generation resuscitation devices that are enhancing patient safety and clinical outcomes.

  • In July 2025, Synchrony Medical received FDA 510(k) clearance for its LibAirty Airway Clearance System, marking a significant advancement in home-based respiratory care.

  • In June 2025, the Sonu device, an AI-enabled wearable for nasal congestion relief, received expanded FDA approval for pediatric patients aged 12 years and older, which was originally cleared in 2023 for adults.

  • In May 2025, SOA25 Congress highlighted comprehensive updates on airway management in ICU settings, featuring new techniques, equipment, and evidence-based practices.

Discover recent advancements in the Airway Management Devices landscape @ Airway Management Devices Recent Developments.

Airway Management Devices Market Dynamics

The airway management devices market demonstrates robust growth momentum, valued at USD 1.60 billion in 2023 and poised to reach USD 2.29 billion by 2030. This substantial expansion reflects the convergence of multiple critical healthcare trends that are reshaping the respiratory care landscape globally.

The market’s primary driving force stems from the escalating burden of chronic respiratory diseases worldwide. According to the Australian Institute of Health and Welfare, approximately 8.5 million (34%) people in Australia were estimated to have chronic respiratory conditions in 2022. Furthermore, Global Burden of Disease data indicates that approximately 1 in 20 people globally suffers from chronic respiratory diseases. This growing patient population necessitates frequent interventions to ensure adequate ventilation and oxygenation, driving increased utilization of devices like endotracheal tubes, laryngeal mask airways, and bag-valve-mask systems.

The airway management devices market is further strengthened by the increasing prevalence of cancer-related respiratory complications. GLOBOCAN data reveals that in 2022, there were 2.48 million estimated new cases of trachea, bronchus, and lung cancer globally, with projections expected to rise to 4.25 million by 2045. Lung cancer often necessitates various surgical interventions, including lobectomies or pneumonectomies, which require effective airway management solutions to ensure proper ventilation and oxygenation during surgery.

Airway management devices market development is characterized by significant technological advancement and innovation. The market is witnessing a surge in product launches and approvals by key market players, introducing innovative solutions and securing regulatory approvals that strategically expand market presence. These developments include breakthrough technologies that stent airways open and monitor end-tidal carbon dioxide accurately, maintaining airway patency and providing precise oxygenation during deep sedation procedures.

The airway management devices market competitive landscape features diverse industry participation, with established medical device manufacturers investing in research and development to capture market share. Companies are focusing on developing ergonomically improved handles, disposable or reusable blades, and advanced video laryngoscopy systems that cater to diverse clinical needs and enhance user comfort and safety.

However, the market faces challenges, including risks and complications such as trauma to the airway, accidental extubation, aspiration, and stringent regulatory concerns for product approval. Despite these hurdles, the overall market outlook remains positive, driven by increasing awareness and screening programs that promote early detection and better management of respiratory issues, amplifying the need for advanced airway management devices.

Download the Airway Management Devices Market report to understand which factors are driving the therapeutic market @ Airway Management Devices Market Trends.

Airway Management Devices Potential Patient Pool

The airway management devices market report provides a comprehensive epidemiological analysis across major global markets, with particular focus on respiratory disease prevalence and airway management requirements.

DelveInsight’s analysis segments patient populations based on chronic respiratory conditions, including asthma, COPD, and cancer-related respiratory complications across different demographic groups.

According to DelveInsight’s data, approximately 1 in 20 people globally suffers from chronic respiratory diseases. In Australia alone, 8.5 million (34%) people were estimated to have chronic respiratory conditions in 2022. The airway management devices eligible patient pool includes individuals requiring airway management across emergency medicine, anesthesia, and critical care settings, with particular emphasis on surgical patients and those with chronic respiratory conditions.

North America is expected to dominate the market, followed by Europe and the Asia-Pacific regions. In North America, there were approximately 13,000 new cases of laryngeal cancer and about 18,000 new cases of oropharynx and nasopharynx cancer in 2022.

Discover evolving trends in the Airway Management Devices patient pool forecasts @ Airway Management Devices Patient Pool Analysis.

Airway Management Devices Key Companies and Competitive Landscape

The airway management devices market represents a dynamic therapeutic landscape characterized by continuous innovation and strategic development across multiple clinical applications. Current treatment paradigms encompass a comprehensive range of devices designed for emergency medicine, anesthesia, and critical care settings, with laryngoscopes emerging as the dominant segment due to their essential role in airway patency maintenance during medical procedures.

The airway management devices innopvation and development activity demonstrates robust development across multiple phases, with companies investing significantly in advanced technologies, including video laryngoscopy systems, AI-assisted placement algorithms, and enhanced visualization capabilities. The market benefits from ongoing innovations in device design, featuring ergonomically improved handles and disposable or reusable blade options that address diverse clinical needs while enhancing user comfort and safety.

Key players include Smiths Medical PLC (advanced laryngoscopy solutions), Narang Medical Limited (comprehensive airway management portfolio), Intersurgical Ltd. (respiratory care devices), Teleflex Incorporated (GlideScope® Spectrum™ QC featuring QuickConnect™ technology), Stryker Corporation (surgical airway solutions), Medtronic PLC (integrated respiratory systems), Dilon Technologies® Inc. (specialized airway devices), Ambu A/S (single-use laryngoscopes), and Medline Industries, LP (comprehensive medical supplies). These companies maintain strong market positioning through their established product portfolios and continuous innovation capabilities.

The airway management devices competitive landscape reflects sophisticated market positioning, with companies leveraging technological advancements to differentiate their offerings. Drug profiles and device mechanisms focus on improving visualization capabilities, reducing procedure complexity, and enhancing patient safety outcomes. Recent development milestones include significant regulatory achievements such as FDA 510(k) clearances for AI-assisted placement algorithms and advanced video laryngoscopy systems that provide enhanced visibility through high-definition cameras and monitors.

DelveInsight’s commercial arrangements analysis demonstrates strategic collaboration patterns, with companies pursuing licensing deals and partnerships to expand their technological capabilities and market reach. The market continues to evolve through strategic acquisitions and joint ventures that enable companies to access complementary technologies and expand their product portfolios across different therapeutic segments.

Delve deeper into the major and specialised companies in the Airway Management Devices market @ Airway Management Devices Competitive Landscape.

Conclusion

DelveInsight’s comprehensive analysis reveals a robust and expanding airway management devices market positioned for significant growth through 2030. The convergence of rising respiratory disease prevalence, increasing surgical procedures, technological innovation, and expanding healthcare infrastructure creates a compelling investment opportunity within the medical device sector. As healthcare providers continue to prioritize patient safety and procedural efficiency, the airway management devices market represents a critical component of modern respiratory care, with sustained growth prospects driven by both clinical necessity and technological advancement.

Table of Contents

1. Airway Management Devices Market Report Introduction

2. Airway Management Devices Market Executive Summary

3. Competitive Landscape

4. Regulatory Analysis

5. Airway Management Devices Market Key Factors Analysis

6. Airway Management Devices Market Porter’s Five Forces Analysis

7. Airway Management Devices Market Assessment

8. Airway Management Devices Market Company and Product Profiles

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

About DelveInsight

DelveInsight is a leading business consulting and market research company focused on the healthcare and life sciences sectors, providing comprehensive market intelligence, competitive landscape analysis, and strategic insights to support decision-making across the pharmaceutical industry.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services